Clinical Trial

Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second Trial

Study acronym: UP2025
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Small cutaneous ulcers are common in Papua New Guinea but are normally left untreated due to lack of easy access to basic medicines. The goal of this clinical trial is to test the efficacy of a readily available antibacterial plant medicine called Pterocarpus indicus comparing healing outcomes to control arms receiving Savlon antiseptic cream and no treatment. Participants with cutaneous ulcers less than 1cm in diameter will be randomized to receive topical treatment with a plant medicines, Savlon cream or no treatment treatment and followed up at day 7 and 14 to assess ulcer healing and ulcer surface area.
Protocol Amendment History 1 change
minor Completion pushed: 2026-03-30 -> 2026-09-30 2026-07-17
Trial Details
NCT Number NCT07264686
Lead Sponsor Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Collaborators: The Royal Botanic Gardens, Kew
Conditions Cutaneous Ulcer Disease, Skin Sores
Enrollment 222 participants
Start Date 2025-11-03
Primary Completion 2025-11-21 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-16